Forbes August 15, 2022
Topline
The U.K. has authorized Moderna’s Covid vaccine that targets two different variants of the virus, the nation’s medicines regulator announced on Monday, a world first as pharma firms adapt to a changed viral landscape and countries prepare to launch fall booster campaigns.
Key Facts
Key Background
The virus circulating today has shifted significantly from the original one identified back in 2020. Vaccines, meanwhile, are still based on the original variant and while they still provide strong protection against serious illness, hospitalization and death, experts fear this could change with future variants. Most major Covid vaccine makers—including Pfizer, Moderna, Johnson & Johnson and Novavax—have been working on shots specific to the omicron variant to address waning effectiveness against the variant...